John C. Morris, III, M.D.

  1. Endocrinologist
  2. Internist
  1. Ramai D, Smith ER, Wang Y, Huang Y, Obaitan I, Chandan S, Dhindsa B, Papaefthymiou A, Morris JD. Epidemiology and Socioeconomic Impact of Pancreatic Cancer: An Analysis of the Global Burden of Disease Study 1990-2019. Dig Dis Sci. 2024 Feb 21 [Epub ahead of print]
    View PubMed
  2. Joseph-Mathurin N, Feldman RL, Lu R, Shirzadi Z, Toomer C, Saint Clair JR, Ma Y, McKay NS, Strain JF, Kilgore C, Friedrichsen KA, Chen CD, Gordon BA, Chen G, Hornbeck RC, Massoumzadeh P, McCullough AA, Wang Q, Li Y, Wang G, Keefe SJ, Schultz SA, Cruchaga C, Preboske GM, Jack CR Jr, Llibre-Guerra JJ, Allegri RF, Ances BM, Berman SB, Brooks WS, Cash DM, Day GS, Fox NC, Fulham M, Ghetti B, Johnson KA, Jucker M, Klunk WE, la Fougere C, Levin J, Niimi Y, Oh H, Perrin RJ, Reischl G, Ringman JM, Saykin AJ, Schofield PR, Su Y, Supnet-Bell C, Voglein J, Yakushev I, Brickman AM, Morris JC, McDade E, Xiong C, Bateman RJ, Chhatwal JP, Benzinger TLS, Dominantly Inherited Alzheimer Network. Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage. Alzheimers Dement. 2024 Feb 21 [Epub ahead of print]
    View PubMed
  3. Satyadev N, Tipton PW, Martens Y, Dunham SR, Geschwind MD, Morris JC, Brier MR, Graff-Radford NR, Day GS. Improving Early Recognition of Treatment-Responsive Causes of Rapidly Progressive Dementia: The STAM(3) P Score. Ann Neurol. 2024 Feb; 95 (2):237-248 Epub 2023 Oct 19
    View PubMed
  4. Singh Ospina N, Patel Chavez C, Godinez Leiva E, Bagautdinova D, Hidalgo J, Hartasanchez S, Algarin Perneth S, Barb D, Danan D, Dziegielewski P, Hughley B, Srihari A, Subbarayan S, Castro MR, Dean D, Morris J, Ryder M, Stan MN, Hargraves I, Bylund CL, Treise D, Montori VM, Brito JP. Clinician feedback using a shared decision-making tool for the evaluation of patients with thyroid nodules-an observational study. Endocrine. 2024 Feb; 83 (2):449-458 Epub 2023 Sept 11
    View PubMed
  5. Toro-Tobon D, Morris JC, Hilger C, Peskey C, Durski JM, Ryder M. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers. Thyroid. 2024 Jan; 34 (1):70-81 Epub 2023 Dec 12
    View PubMed
  6. De Braud F, Deschler-Baier B, Morris JC 3rd, Worden F, Han Y, Kiiskinen U, Jen MH, Barker SS, Szymczak S, Gilligan AM. Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001. Cancers (Basel). 2023 Dec 27; 16 (1)
    View PubMed
  7. Millar PR, Gordon BA, Wisch JK, Schultz SA, Benzinger TL, Cruchaga C, Hassenstab JJ, Ibanez L, Karch C, Llibre-Guerra JJ, Morris JC, Perrin RJ, Supnet-Bell C, Xiong C, Allegri RF, Berman SB, Chhatwal JP, Chrem Mendez PA, Day GS, Hofmann A, Ikeuchi T, Jucker M, Lee JH, Levin J, Lopera F, Niimi Y, Sanchez-Gonzalez VJ, Schofield PR, Sosa-Ortiz AL, Voglein J, Bateman RJ, Ances BM, McDade EM, Dominantly Inherited Alzheimer Network. Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease. Mol Neurodegener. 2023 Dec 19; 18 (1):98
    View PubMed
  8. Patel Chavez CP, Godinez Leiva E, Bagautdinova D, Hidalgo J, Hartasanchez S, Barb D, Danan D, Dziegielewski P, Edwards C, Hughley B, Srihari A, Subbarayan S, Castro MR, Dean D, Morris J, Ryder M, Stan MN, Hargraves I, Shepel K, Brito JP, Bylund CL, Treise D, Montori V, Singh Ospina N. Patient feedback receiving care using a shared decision making tool for thyroid nodule evaluation-an observational study. Endocrine. 2023 Apr; 80 (1):124-133 Epub 2022 Dec 19
    View PubMed
  9. Millar PR, Luckett PH, Gordon BA, Benzinger TLS, Schindler SE, Fagan AM, Cruchaga C, Bateman RJ, Allegri R, Jucker M, Lee JH, Mori H, Salloway SP, Yakushev I, Morris JC, Ances BM, Dominantly Inherited Alzheimer Network. Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease. Neuroimage. 2022 Aug 1; 256:119228 Epub 2022 Apr 20
    View PubMed
  10. Hassan Nelson L, Fuentes-Bayne H, Yin J, Asmus E, Ryder M, Morris JC, Hilger CR, Bible KC, Chintakuntlawar AV, Rao SN. Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas. J Endocr Soc. 2022 May 1; 6 (5):bvac044 Epub 2022 Mar 22
    View PubMed
  11. Gao RW, Foote RL, Garces YI, Ma DJ, Neben-Wittich M, Routman DM, Patel SH, Ko SJ, McGee LA, Bible KC, Chintakuntlawar AV, Ryder M, Morris JC, Van Abel KM, Rivera M, Abraha F, Lester SC. Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy. Pract Radiat Oncol. 2022 Mar-Apr; 12 (2):113-119 Epub 2021 Oct 26
    View PubMed
  12. Szabo Yamashita T, Rogers RT, Foster TR, Lyden ML, Morris JC, Thompson GB, McKenzie T, Dy BM. Medullary thyroid cancer: What is the optimal management of the lateral neck in a node negative patient at index operation? Surgery. 2022 Jan; 171 (1):177-181 Epub 2021 July 18
    View PubMed
  13. Genere N, El Kawkgi OM, Giblon RE, Vaccarella S, Morris JC, Hay ID, Brito JP. Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study. Mayo Clin Proc. 2021 Nov; 96 (11):2823-2830
    View PubMed
  14. Ryder M, Wentworth M, Algeciras-Schimnich A, Morris JC, Garrity J, Sanders J, Young S, Sanders P, Furmaniak J, Rees Smith B. Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy. Thyroid. 2021 Oct; 31 (10):1597-1602 Epub 2021 July 08
    View PubMed
  15. Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, Poirier J, Vachon-Presseau E, Villeneuve S, Alzheimer's Disease Neuroimaging Initiative (ADNI)//Dominantly Inherited Alzheimer Network (DIAN) Study Group//Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer's Disease (PREVENT-AD) Research Group. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nat Commun. 2021 Sep 9; 12 (1):5346 Epub 2021 Sept 09
    View PubMed
  16. Yamashita TS, Rogers RT, Foster TR, Lyden ML, Morris JC, McKenzie T, Thompson GB, Dy BM. Ultrasound-Guided Percutaneous Ethanol Ablation for Local Regional Recurrence of Medullary Thyroid Cancer. Am Surg. 2021 Sep; 87 (9):1396-1399 Epub 2021 Aug 31
    View PubMed
  17. Pichet Binette A, Vachon-Presseau E, Morris J, Bateman R, Benzinger T, Collins DL, Poirier J, Breitner JCS, Villeneuve S, Dominantly Inherited Alzheimer Network (DIAN)//PREVENT-AD Research Group. Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease. Biol Psychiatry. 2021 Apr 15; 89 (8):776-785 Epub 2020 Feb 06
    View PubMed
  18. Dowling E, Kasperbauer J, Morris J, Bayan S. Acute airway compromise after recombinant human TSH administration: A case report and review of the literature. Laryngoscope. 2020 Nov; 130 (11):2725-2727 Epub 2019 Dec 10
    View PubMed
  19. Hay ID, Lee RA, Kaggal S, Morris JC, Stan MN, Castro MR, Fatourechi V, Thompson GB, Charboneau JW, Reading CC. Long-Term Results of Treating With Ethanol Ablation 15 Adult Patients With cT1aN0 Papillary Thyroid Microcarcinoma. J Endocr Soc. 2020 Nov 1; 4 (11):bvaa135 Epub 2020 Sept 15
    View PubMed
  20. Singer MC, Marchal F, Angelos P, Bernet V, Boucai L, Buchholzer S, Burkey B, Eisele D, Erkul E, Faure F, Freitag SK, Gillespie MB, Harrell RM, Hartl D, Haymart M, Leffert J, Mandel S, Miller BS, Morris J, Pearce EN, Rahmati R, Ryan WR, Schaitkin B, Schlumberger M, Stack BC, Van Nostrand D, Wong KK, Randolph G. Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology. Head Neck. 2020 Nov; 42 (11):3446-3459 Epub 2020 Aug 19
    View PubMed
  21. Li D, El Kawkgi OM, Morris JC 3rd. A Patient with Hyperthyroidism and An Anterior Mediastinal Mass. J Endocr Soc. 2020 Oct 1; 4 (10):bvaa124 Epub 2020 Aug 21
    View PubMed
  22. Yang M, Li X, Morris JC 3rd, Liang J, Deshmukh AJ, Hodge D, Li Y, Cha YM. Outcomes of Cardiac Resynchronization Therapy in Patients with Hypothyroidism and Heart Failure. BMC Cardiovasc Disord. 2020 Sep 23; 20 (1):424 Epub 2020 Sept 23
    View PubMed
  23. Wirth LJ, Sherman E, Robinson B, Solomon B, Kang H, Lorch J, Worden F, Brose M, Patel J, Leboulleux S, Godbert Y, Barlesi F, Morris JC, Owonikoko TK, Tan DSW, Gautschi O, Weiss J, de la Fouchardiere C, Burkard ME, Laskin J, Taylor MH, Kroiss M, Medioni J, Goldman JW, Bauer TM, Levy B, Zhu VW, Lakhani N, Moreno V, Ebata K, Nguyen M, Heirich D, Zhu EY, Huang X, Yang L, Kherani J, Rothenberg SM, Drilon A, Subbiah V, Shah MH, Cabanillas ME. Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. N Engl J Med. 2020 Aug 27; 383 (9):825-835
    View PubMed
  24. Genere N, Hurtado MD, Cortes T, Athimulam S, Al Ward R, Callstrom MR, Stan MN, Morris JC, Brito JP. Drivers of the Decision to Biopsy and Follow-Up of Small Suspicious Thyroid Nodules. Endocr Pract. 2020 Aug; 26 (8):857-868
    View PubMed
  25. Miller KC, Chintakuntlawar AV, Hilger C, Bancos I, Morris JC, Ryder M, Smith CY, Jenkins SM, Bible KC. Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma. J Endocr Soc. 2020 Jul 1; 4 (7):bvaa069 Epub 2020 June 09
    View PubMed
  26. Iniguez-Ariza NM, Jasim S, Ryder MM, Chintakuntlawar AV, Morris JC, Hilger CR, Menefee ME, Smallridge RC, Karlin NJ, Alcaino C, Bible KC. Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy. J Clin Endocrinol Metab. 2020 Jul 1; 105 (7)
    View PubMed
  27. Genere N, Hurtado MD, Cortes T, Athimulam S, Al Ward R, Callstrom MR, Stan MN, Morris JC, Brito JP. DRIVERS OF THE DECISION TO BIOPSY AND FOLLOW-UP OF SMALL SUSPICIOUS THYROID NODULES. Endocr Pract. 2020 May 14 [Epub ahead of print]
    View PubMed
  28. Gonzales KM, Stan MN, Morris JC 3rd, Bernet V, Castro MR. The Levothyroxine Absorption Test: A Four-Year Experience (2015-2018) at The Mayo Clinic. Thyroid. 2019 Dec; 29 (12):1734-1742 Epub 2019 Dec 04
    View PubMed
  29. Chintakuntlawar AV, Yin J, Foote RL, Kasperbauer JL, Rivera M, Asmus E, Garces Y, Garces NI, Janus JR, Liu M, Ma DJ, Moore EJ, Morris JC 3rd, Neben-Wittich M, Price DL, Price KA, Ryder M, Van Abel KM, Hilger C, Samb E, Bible KC. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer. Thyroid. 2019 Nov; 29 (11):1615-1622
    View PubMed
  30. Morris JC, Galton VA. The isolation of thyroxine (T4), the discovery of 3,5,3'-triiodothyronine (T3), and the identification of the deiodinases that generate T3 from T4: An historical review. Endocrine. 2019 Oct; 66 (1):3-9 Epub 2019 June 29
    View PubMed
  31. Meltzer CJ, Irish J, Angelos P, Busaidy NL, Davies L, Dwojak S, Ferris RL, Haugen BR, Harrell RM, Haymart MR, McIver B, Mechanick JI, Monteiro E, Morris JC 3rd, Morris LGT, Odell M, Scharpf J, Shaha A, Shin JJ, Shonka DC Jr, Thompson GB, Tuttle RM, Urken ML, Wiseman SM, Wong RJ, Randolph G. American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules. Head Neck. 2019 Apr; 41 (4):843-856 Epub 2018 Dec 18
    View PubMed
  32. Stack BC Jr, Tolley NS, Bartel TB, Bilezikian JP, Bodenner D, Camacho P, Cox JPDT, Dralle H, Jackson JE, Morris JC 3rd, Orloff LA, Palazzo F, Ridge JA, Scott-Coombes D, Steward DL, Terris DJ, Thompson G, Randolph GW. AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons. Head Neck. 2018 Aug; 40 (8):1617-1629 Epub 2018 Aug 02
    View PubMed
  33. Hamidi O, Callstrom MR, Lee RA, Dean D, Castro MR, Morris JC, Stan MN. Outcomes of Radiofrequency Ablation Therapy for Large Benign Thyroid Nodules: A Mayo Clinic Case Series. Mayo Clin Proc. 2018 Aug; 93 (8):1018-1025 Epub 2018 Mar 21
    View PubMed
  34. Fundakowski CE, Hales NW, Agrawal N, Barczynski M, Camacho PM, Hartl DM, Kandil E, Liddy WE, McKenzie TJ, Morris JC, Ridge JA, Schneider R, Serpell J, Sinclair CF, Snyder SK, Terris DJ, Tuttle RM, Wu CW, Wong RJ, Zafereo M, Randolph GW. Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement. Head Neck. 2018 Apr; 40 (4):663-675 Epub 2018 Feb 20
    View PubMed
  35. Prasongsook N, Kumar A, Chintakuntlawar AV, Foote RL, Kasperbauer J, Molina J, Garces Y, Ma D, Neben Wittich MA, Wittich MAN, Rubin J, Richardson R, Morris J, Hay I, Fatourechi V, McIver B, Ryder M, Thompson G, Grant C, Richards M, Sebo TJ, Rivera M, Suman V, Jenkins SM, Smallridge RC, Bible KC. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer. J Clin Endocrinol Metab. 2017 Dec 1; 102 (12):4506-4514
    View PubMed
  36. Singh Ospina N, Ospina NS, Maraka S, Donegan D, Morris JC. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation. Thyroid. 2017 Oct; 27 (10):1332-1334 Epub 2017 Sept 05
    View PubMed
  37. Jasim S, Iniguez-Ariza NM, Hilger CR, Chintakuntlawar AV, Ryder MM, Morris JC 3rd, Bible KC. OPTIMIZING LENVATINIB THERAPY IN PATIENTS WITH METASTATIC RADIOACTIVE IODINE-RESISTANT DIFFERENTIATED THYROID CANCERS. Endocr Pract. 2017 Aug 17;
    View PubMed
  38. Nguyen TV, Barry ME, Turner MA, Crosby CM, Trujillo MA, Morris JC, Barry MA. Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5. Biomedicines. 2017 Aug 10; 5 (3)
    View PubMed
  39. Chintakuntlawar AV, Rumilla KM, Smith CY, Jenkins SM, Foote RL, Kasperbauer JL, Morris JC, Ryder M, Alsidawi S, Hilger C, Bible KC. Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study. J Clin Endocrinol Metab. 2017 Jun 01; 102(6):1943-1950.
    View PubMed
  40. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, Mandel SJ, Morris JC, Nassar A, Pacini F, Schlumberger M, Schuff K, Sherman SI, Somerset H, Sosa JA, Steward DL, Wartofsky L, Williams MD. American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid. 2017 Apr; 27 (4):481-483 Epub 2017 Feb 21
    View PubMed
  41. Vanden Borre P, Schrock AB, Anderson PM, Morris JC 3rd, Heilmann AM, Holmes O, Wang K, Johnson A, Waguespack SG, Ou SI, Khan S, Fung KM, Stephens PJ, Erlich RL, Miller VA, Ross JS, Ali SM. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions. Oncologist. 2017 Mar; 22 (3):255-263 Epub 2017 Feb 16
    View PubMed
  42. Espinosa De Ycaza AE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, Morris JC, Stan MN. Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study. Thyroid. 2016 Nov; 26 (11):1598-1604 Epub 2016 Oct 05
    View PubMed
  43. Singh Ospina N, Maraka S, Espinosa De Ycaza AE, Ahn HS, Castro MR, Morris JC, Montori VM, Brito JP. Physical exam in asymptomatic people drivers the detection of thyroid nodules undergoing ultrasound guided fine needle aspiration biopsy. Endocrine. 2016 Nov; 54 (2):433-439 Epub 2016 Aug 10
    View PubMed
  44. Singh Ospina N, Maraka S, Espinosa de Ycaza AE, Brito JP, Castro MR, Morris JC, Montori VM. Prognosis of patients with benign thyroid nodules: a population-based study. Endocrine. 2016 Oct; 54 (1):148-155 Epub 2016 May 03
    View PubMed
  45. Singh Ospina N, Brito JP, Maraka S, Espinosa de Ycaza AE, Rodriguez-Gutierrez R, Gionfriddo MR, Castaneda-Guarderas A, Benkhadra K, Al Nofal A, Erwin P, Morris JC, Castro MR, Montori VM. Diagnostic accuracy of ultrasound-guided fine needle aspiration biopsy for thyroid malignancy: systematic review and meta-analysis. Endocrine. 2016 Sep; 53 (3):651-61 Epub 2016 Apr 12
    View PubMed
  46. Brito JP, Singh Ospina NM, Morris JC. Ramifications of New Terminology for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma. JAMA Oncol 2016 Aug 1; 2 (8):1097
    View PubMed
  47. Singh Ospina N, Maraka S, Espinosa DeYcaza A, O'Keeffe D, Brito JP, Gionfriddo MR, Castro MR, Morris JC, Erwin P, Montori VM. Diagnostic accuracy of thyroid nodule growth to predict malignancy in thyroid nodules with benign cytology: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2016 Jul; 85 (1):122-31 Epub 2016 Jan 25
    View PubMed
  48. Spitzweg C, Morris JC, Bible KC. New drugs for medullary thyroid cancer: new promises? Endocr Relat Cancer. 2016 Jun; 23: (6)R287-97.
    View PubMed
  49. Brito JP, Singh-Ospina N, Gionfriddo MR, Maraka S, Espinosa De Ycaza A, Rodriguez-Gutierrez R, Morris JC, Montori VM, Tuttle RM. Restricting ultrasound thyroid fine needle aspiration biopsy by nodule size: which tumors are we missing? A population-based study. Endocrine. 2016 Mar; 51 (3):499-505 Epub 2015 Aug 09
    View PubMed
  50. Deming Y, Xia J, Cai Y, Lord J, Del-Aguila JL, Fernandez MV, Carrell D, Black K, Budde J, Ma S, Saef B, Howells B, Bertelsen S, Bailey M, Ridge PG, Holtzman D, Morris JC, Bales K, Pickering EH, Lee JM, Heitsch L, Kauwe J, Goate A, Piccio L, Cruchaga C, Alzheimer's Disease Neuroimaging Initiative (ADNI). Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits. Sci Rep. 2016 Jan 4; 6 (1):18092 Epub 2016 Jan 04
    View PubMed
  51. Singh Ospina N, Sebo TJ, Morris JC, Castro MR. The Value of Repeat Thyroid Fine-Needle Aspiration Biopsy in Patients with a Previously Benign Result: How Often Does It Alter Management? Thyroid. 2015 Oct; 25: (10)1121-6.
    View PubMed
  52. Brito JP, Al Nofal A, Montori VM, Hay ID, Morris JC. The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012. Thyroid. 2015 Sep; 25 (9):999-1007 Epub 2015 July 30
    View PubMed
  53. Davies L, Morris LGT, Haymart M, Chen AY, Goldenberg D, Morris J, Ogilvie JB, Terris DJ, Netterville J, Wong RJ, Randolph G. American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyriod cancer. Endocr Pract. 2015 Jun; 21(6):686-96.
    View PubMed
  54. Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Rogaeva E, Lin CF, Dombroski BA, Cantwell LB, Partch A, Valladares O, Hakonarson H, St George-Hyslop P, Green RC, Goate AM, Foroud TM, Carney RM, Larson EB, Behrens TW, Kauwe JS, Haines JL, Farrer LA, Pericak-Vance MA, Mayeux R, Schellenberg GD, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barmada M, Barnes LL, Beach TG, Becker JT, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carroll SL, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Demirci FY, Dick M, Dickson DW, Duara R, Ertekin-Taner N, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Graff-Radford NR, Growdon JH, Hamilton RL, Hamilton-Nelson KL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Jun G, Kamboh MI, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lopez OL, Lunetta KL, Lyketsos CG, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam WM, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Murrell JR, Olichney JM, Parisi JE, Perry W, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L, Alzheimer's Disease Genetics Consortium//National Institute on Aging-Late-Onset Alzheimer's Disease (NIA-LOAD) Family Study. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72 (2):209-16
    View PubMed
  55. Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC, Dominantly Inherited Alzheimer Network. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Curr Neurol Neurosci Rep. 2014 Nov; 14 (11):499
    View PubMed
  56. McIver B, Castro MR, Morris JC, Bernet V, Smallridge R, Henry M, Kosok L, Reddi H. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2014 Nov; 99 (11):4069-77 Epub 2014 Apr 29
    View PubMed
  57. Spitzweg C, Bible KC, Hofbauer LC, Morris JC. Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets. Lancet Diabetes Endocrinol. 2014 Oct; 2 (10):830-42 Epub 2014 June 02
    View PubMed
  58. Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer. BMJ. 2014 Jun 16; 348:g3045 Epub 2014 June 16
    View PubMed
  59. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C, Endocrine Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, and the Mayo Phase 2 Consortium. A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H. J Clin Endocrinol Metab. 2014 May; 99 (5):1687-93 Epub 2014 Feb 25
    View PubMed
  60. Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, Callstrom M, Elraiyah TA, Prokop LJ, Stan MN, Murad MH, Morris JC, Montori VM. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Apr; 99 (4):1253-63 Epub 2013 Nov 25
    View PubMed
  61. Castro MR, Thomas BC, Richards ML, Zhang J, Morris JC. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred. Thyroid. 2013 Dec; 23 (12):1547-52 Epub 2013 July 25
    View PubMed
  62. Mehrmohammadi M, Song P, Carrascal CA, Urban MW, Callstrom MR, Morris JC, Chen S, Greenleaf JF, Fatemi M, Alizad A. Application of shear wave imaging and shear wave dispersion ultrasound vibrometry in assessing viscoelastic properties of human thyroid: In vivo pilot study. J Acoust Soc Am. 2013 Nov; 134(5):4009.
  63. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013 Aug 27; 347:f4706
    View PubMed
  64. Trujillo MA, Oneal MJ, McDonough SJ, Morris JC. Viral dose, radioiodide uptake, and delayed efflux in adenovirus-mediated NIS radiovirotherapy correlates with treatment efficacy. Gene Ther. 2013 May; 20 (5):567-74 Epub 2012 Sept 13
    View PubMed
  65. Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, De Jager PL, Chibnik L, Bennett DA, Arnold SE, Harold D, Sims R, Gerrish A, Williams J, Van Deerlin VM, Lee VM, Shaw LM, Trojanowski JQ, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Peskind ER, Galasko D, Fagan AM, Holtzman DM, Morris JC, Goate AM, GERAD Consortium//Alzheimer's Disease Neuroimaging Initiative (ADNI)//Alzheimer Disease Genetic Consortium (ADGC). GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78 (2):256-68 Epub 2013 Apr 04
    View PubMed
  66. Alizad A, Urban MW, Morris JC, Reading CC, Kinnick RR, Greenleaf JF, Fatemi M. In vivo thyroid vibro-acoustography: a pilot study. BMC Med Imaging. 2013 Mar 27; 13:12
    View PubMed
  67. Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC. A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer. Cancer Gene Ther. 2012 Dec; 19 (12):839-44 Epub 2012 Oct 05
    View PubMed
  68. Oneal MJ, Trujillo MA, Davydova J, McDonough S, Yamamoto M, Morris JC 3rd. Characterization of infectivity-enhanced conditionally replicating adenovectors for prostate cancer radiovirotherapy. Hum Gene Ther. 2012 Sep; 23 (9):951-9 Epub 2012 Aug 22
    View PubMed
  69. Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC 3rd, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Cancer Gene Ther. 2012 Sep; 19 (9):659-65 Epub 2012 July 13
    View PubMed
  70. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8 (3 Suppl):e1s-5s
    View PubMed
  71. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May 1; 18 (5):e162-7 Epub 2012 May 01
    View PubMed
  72. Ahmed KA, Davis BJ, Wilson TM, Wiseman GA, Federspiel MJ, Morris JC. Progress in gene therapy for prostate cancer. Front Oncol. 2012; 2:172 Epub 2012 Nov 19
    View PubMed
  73. Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC. Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid. 2011 Nov; 21 (11):1191-8 Epub 2011 Oct 18
    View PubMed
  74. Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW, Liu Z, Flavin R, O'Flatharta C, Foley MJ, Barrett HH, Murphy JM, Barry FP, O'Brien T, Kerin MJ. Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells. 2011 Jul; 29(7):1149-57.
    View PubMed
  75. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43 (5):436-41 Epub 2011 Apr 03
    View PubMed
  76. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Ruther E, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Gallacher J, Hull M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alperovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Bjornsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J, Alzheimer's Disease Neuroimaging Initiative//CHARGE consortium//EADI1 consortium, Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011 May; 43 (5):429-35 Epub 2011 Apr 03
    View PubMed
  77. Foote RL, Molina JR, Kasperbauer JL, Lloyd RV, McIver B, Morris JC, Grant CS, Thompson GB, Richards ML, Hay ID, Smallridge RC, Bible KC. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. Thyroid. 2011 Jan; 21 (1):25-30 Epub 2010 Dec 16
    View PubMed
  78. Ryan J, Curran CE, Hennessy E, Newell J, Morris JC, Kerin MJ, Dwyer RM. The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. PLoS One. 2011; 6(1):e16023. Epub 2011 Jan 19.
    View PubMed
  79. Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC. A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer. Gene Ther. 2010 Nov; 17 (11):1325-32 Epub 2010 Apr 29
    View PubMed
  80. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Sideras K, Morris JC 3rd, McIver B, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Goh BC, Tang H, Ivy SP, Erlichman C, Endocrine Malignancies Disease Oriented Group//Mayo Clinic Cancer Center//Mayo Phase 2 Consortium. Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. Lancet Oncol. 2010 Oct; 11 (10):962-72 Epub 2010 Sept 17
    View PubMed
  81. Spitzweg C, Morris JC. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol. 2010 Jun 30; 322(1-2):56-63. Epub 2010 Feb 12.
    View PubMed
  82. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M, Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May; 6(3):202-11.e7.
    View PubMed
  83. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL 3rd, Ferrer I, Llado A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, Lopez de Munain A, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IR, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JP, Troncoso JC, Kril JJ, Kwok JB, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, DeCarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tunon MT, Martinez MC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ, Lee VM. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010 Mar; 42 (3):234-9 Epub 2010 Feb 14
    View PubMed
  84. Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E. Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter. Mol Ther. 2009 Dec; 17 (12):2041-8 Epub 2009 Sept 22
    View PubMed
  85. Morris JC. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clin Endocrinol (Oxf). 2009 May; 70 (5):671-3 Epub 2009 Feb 17
    View PubMed
  86. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009 Apr-Jun; 23 (2):91-101
    View PubMed
  87. Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E. Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate. 2009 Jan 1; 69 (1):82-91
    View PubMed
  88. Trujillo MA, Oneal MJ, Davydova J, Bergert E, Yamamoto M, Morris JC 3rd. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer. Breast Cancer Res. 2009; 11 (4):R53 Epub 2009 July 27
    View PubMed
  89. Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Goke B, Morris JC, Spitzweg C. The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. Eur J Nucl Med Mol Imaging. 2008 Jul; 35(7):1272-81. Epub 2008 Apr 11.
    View PubMed
  90. Khoo TK, Baker CH, Hallanger-Johnson J, Tom AM, Grant CS, Reading CC, Sebo TJ, Morris JC 3rd. Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules. Endocr Pract. 2008 May-Jun; 14 (4):426-31
    View PubMed
  91. Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Goke B, Morris JC, Spitzweg C. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res Treat. 2008 May; 109(2):263-72. Epub 2007 Jul 18.
    View PubMed
  92. Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Goke B, Morris JC, Spitzweg C. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther. 2008 Feb; 15(3):214-23. Epub 2007 Nov 8
    View PubMed
  93. Rao VP, Miyagi N, Ricci D, Carlson SK, Morris JC 3rd, Federspiel MJ, Bailey KR, Russell SJ, McGregor CG. Sodium iodide symporter (hNIS) permits molecular imaging of gene transduction in cardiac transplantation. Transplantation. 2007 Dec 27; 84 (12):1662-6
    View PubMed
  94. Willhauck MJ, Samani BRS, Gildehaus FJ, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Goke B, Morris JC, Spitzweg C. Application of (188)Rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. Journal of Clinical Endocrinology & Metabolism. 2007 Nov; 92(11):4451-8.
  95. Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Hum Gene Ther. 2007 Oct; 18(10):916-24.
    View PubMed
  96. Dingli D, Russell SJ, Morris JC. Reporting transgene expression using NIS. J Cell Biochem. 2007.
  97. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20 (4):210-6
    View PubMed
  98. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum Gene Ther. 2006 Jun; 17 (6):661-8
    View PubMed
  99. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther. 2006 Jan; 13 (1):60-6
    View PubMed
  100. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol. 2006 Jan-Feb; 8 (1):16-23
    View PubMed
  101. Unterholzner S, Willhauck MJ, Cengic N, Schutz M, Goke B, Morris JC, Spitzweg C. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J Clin Endocrinol Metab. 2006 Jan; 91(1):69-78. Epub 2005 Oct 18.
    View PubMed
  102. Stan M, Morris JC. Thyrotropin-axis adaptation in aging and chronic disease. Endocrinol Metab Clin North Am. 2005 Dec; 34(4):973-92, x.
    View PubMed
  103. Dingli D, Peng KW, Harvey ME, Vongpunsawad S, Bergert ER, Kyle RA, Cattaneo R, Morris JC, Russell SJ. Interaction of measles virus vectors with Auger electron emitting radioisotopes. Biochem Biophys Res Commun. 2005 Nov 11; 337 (1):22-9
    View PubMed
  104. Dwyer RM, Schatz SM, Bergert ER, Myers RM, Harvey ME, Classic KL, Blanco MC, Frisk CS, Marler RJ, Davis BJ, O'Connor MK, Russell SJ, Morris JC. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer. Mol Ther. 2005 Nov; 12 (5):835-41 Epub 2005 July 27
    View PubMed
  105. Cengic N, Baker CH, Schutz M, Goke B, Morris JC, Spitzweg C. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. J Clin Endocrinol Metab. 2005 Aug; 90(8):4457-64.
    View PubMed
  106. Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Clin Cancer Res. 2005 Feb 15; 11 (4):1483-9
    View PubMed
  107. Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Goke B, Morris JC, Spitzweg C. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Ther. 2005 Feb; 12(3):272-80.
    View PubMed
  108. Dingli D, Bergert ER, Bajzer Z, O'connor MK, Russell SJ, Morris JC. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochem Biophys Res Commun. 2004 Dec 3; 325 (1):157-66
    View PubMed
  109. Baker CH, Morris JC. The sodium-iodide symporter. Current Drug Targets - Immune Endocrine & Metabolic Disorders. 2004 Sep; 4(3):167-74.
  110. Guo J, Pichurin PN, Morris JC, Rapoport B, McLachlan SM. Naked deoxyribonucleic acid vaccination induces recognition of diverse thyroid peroxidase T cell epitopes. Endocrinology. 2004 Aug; 145(8):3671-8. Epub 2004 May 03.
    View PubMed
  111. Spitzweg C, Morris JC. Gene therapy for thyroid cancer: Current status and future prospects. Thyroid. 2004 Jun; 14(6):424-34.
    View PubMed
  112. Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC, Russell SJ. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood. 2004 Mar 1; 103 (5):1641-6 Epub 2003 Nov 06
    View PubMed
  113. Scholz IV, Cengic N, Goke B, Morris JC, Spitzweg C. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter. J Clin Endocrinol Metab. 2004 Mar; 89(3):1108-16.
    View PubMed
  114. Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC. Effects of reducing the upper limit of normal TSH values. JAMA: Journal of the American Medical Association. 2003 Dec 24; 290(24):3195-6.
    View PubMed
  115. Dingli D, Russell SJ, Morris JC 3rd. In vivo imaging and tumor therapy with the sodium iodide symporter. J Cell Biochem. 2003 Dec 15; 90 (6):1079-86
    View PubMed
  116. Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res. 2003 Nov 15; 63 (22):7840-4
    View PubMed
  117. Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CYF, Goke B, Morris JC. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells. Endocrinology. 2003 Aug; 144(8):3423-32.
    View PubMed
  118. Dobert N, Hamscho N, Bergert ER, Oeschger S, Berner U, Goellner J, Menzel C, Morris JC, Grunwald F. Pancreatic carcinoma with positive iodine uptake lacking NIS-protein-expression. Nuklearmedizin. 2003 Aug; 42(4):N42-4.
    View PubMed
  119. Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC, Russell SJ. Genetically targeted radiotherapy for multiple myeloma. Blood. 2003 Jul 15; 102 (2):489-96 Epub 2003 Mar 20
    View PubMed
  120. Preissner CM, O'Kane DJ, Singh RJ, Morris JC, Grebe SK. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab. 2003 Jul; 88 (7):3069-74
    View PubMed
  121. Schwarz-Lauer L, Pichurin PN, Chen CR, Nagayama Y, Paras C, Morris JC, Rapoport B, McLachlan SM. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology. 2003 May; 144(5):1718-25.
    View PubMed
  122. Spitzweg C, Morris JC. The sodium iodide symporter: its pathophysiological and therapeutic implications [Review]. Clin Endocrinol (Oxf). 2002 Nov; 57: (5)559-74.
    View PubMed
  123. Pichurin P, Schwarz-Lauer L, Braley-Mullen H, Paras C, Pichurina O, Morris JC, Rapoport B, McLachlan SM. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA. Thyroid. 2002 Sep; 12(9):755-64.
    View PubMed
  124. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab. 2002 Sep; 87(9):4154-9.
    View PubMed
  125. Spitzweg C, Morris JC. Sodium Iodide Symporter (NIS) and thyroid. Hormone. 2002; 1:22-34.
  126. Morris JC. Surgical treatment of inflammatory disease of the thyroid. Endocr Pract. 2002; 8(4):313-4.
    View PubMed
  127. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab. 2001 Nov; 86 (11):5627-32
    View PubMed
  128. Harrington KJ, Spitzweg C, Bateman AR, Morris JC, Morris JC, Vile RG. Gene therapy for prostate cancer: current status and future prospects. J Urol. 2001 Oct; 166 (4):1220-33
    View PubMed
  129. Pinke LA, Dean DS, Bergert ER, Spitzweg C, Dutton CM, Morris JC. Cloning of the mouse sodium iodide symporter. Thyroid. 2001 Oct; 11 (10):935-9
    View PubMed
  130. Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther. 2001 Oct; 8 (20):1524-31
    View PubMed
  131. Smallridge RC, Castro MR, Morris JC, Young PR, Reynolds JC, Merino MJ, Sarlis NJ. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression. Thyroid. 2001 Aug; 11 (8):795-804
    View PubMed
  132. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab. 2001 Jul; 86 (7):3327-35
    View PubMed
  133. Graves JW, Morris JC, Sheps SG. Martorell's hypertensive leg ulcer: case report and concise review of the literature. J Hum Hypertens. 2001 Apr; 15(4):279-83.
    View PubMed
  134. Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC. Expression of the sodium iodide symporter in human kidney. Kidney Int. 2001 Mar; 59 (3):1013-23
    View PubMed
  135. Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc. 2001 Feb; 76 (2):161-8
    View PubMed
  136. Mitchell AM, Manley SW, Morris JC, Powell KA, Bergert ER, Mortimer RH. Sodium iodide symporter (NIS) gene expression in human placenta. Placenta. 2001 Feb-Mar; 22(2-3):256-8.
    View PubMed
  137. Spitzweg C, Morris JC. Approaches to gene therapy with sodium/iodide symporter. Exp Clin Endocrinol Diabetes. 2001; 109 (1):56-9
    View PubMed
  138. Spitzweg C, Bergert ER, Morris JC. Sodium iodide symporter: Its biology, clinical relevance, and potential role in the pathophysiology of autoimmune thyroid disease. Current Opinion in Endocrinology & Diabetes. 2001; 8(5):259-265.
  139. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res. 2000 Nov 15; 60 (22):6526-30
    View PubMed
  140. Spitzweg C, Morris JC, Morris JC. The immune response to the iodide transporter. Endocrinol Metab Clin North Am. 2000 Jun; 29 (2):389-98, viii
    View PubMed
  141. Spitzweg C, Heufelder AE, Morris JC. Thyroid iodine transport. Thyroid. 2000 Apr; 10 (4):321-30
    View PubMed
  142. Castro MR, Kocher D, Morris JC. An unusual case of inappropriate secretion of thyrotropin: neoplastic or nonneoplastic? Endocr Pract. 2000 Jan-Feb; 6 (1):29-33
    View PubMed
  143. Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC, Morris JC. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol. 1999 Dec; 163 (3):495-504
    View PubMed
  144. Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab. 1999 Nov; 84 (11):4178-84
    View PubMed
  145. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB, Morris JC. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab. 1999 Sep; 84(9):3328-35.
    View PubMed
  146. Castro MR, Bergert ER, Beito TG, McIver B, Goellner JR, Morris JC. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. J Clin Endocrinol Metab. 1999 Aug; 84(8):2957-62.
    View PubMed
  147. Spitzweg C, Joba W, Morris JC, Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid. 1999 Aug; 9 (8):821-30
    View PubMed
  148. Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res. 1999 May 1; 59 (9):2136-41
    View PubMed
  149. Morris JC. The clinical expression of thyrotropin receptor mutations. Endocrinologist. 1998 May; 8(3):195-201.
  150. McIver B, Morris JC, Morris JC. The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am. 1998 Mar; 27 (1):73-89
    View PubMed
  151. Raju R, Navaneetham D, Kellermann SA, Freeman SL, Morris JC, McCormick DJ, Conti-Fine BM. TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans. J Autoimmun. 1997 Oct; 10(5):479-89.
    View PubMed
  152. Morris JC, Bergert ER, Bryant WP. Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen. Thyroid. 1997 Aug; 7 (4):527-34
    View PubMed
  153. Campbell RK, Bergert ER, Wang Y, Morris JC, Moyle WR. Chimeric proteins can exceed the sum of their parts: implications for evolution and protein design. Nat Biotechnol. 1997 May; 15(5):439-43.
    View PubMed
  154. Fu AZ, Morris JC, Ford GC, Nair KS. Sequential purification of human apolipoprotein B-100, albumin, and fibrinogen by immunoaffinity chromatography for measurement of protein synthesis. Anal Biochem. 1997 May 1; 247(2):228-36.
    View PubMed
  155. Morris JC. Structure and function of the TSH receptor: its suitability as a target for radiotherapy. Thyroid. 1997 Apr; 7(2):253-8.
    View PubMed
  156. Porrata LF, Morris JC 3rd. 63-year-old woman with fever and right flank pain. Mayo Clin Proc. 1996 Oct; 71(10):1011-4.
    View PubMed
  157. Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Endocrinology. 1996 Aug; 137(8):3329-39.
    View PubMed
  158. Vlase H, Nakashima M, Graves PN, Tomer Y, Morris JC, Davies TF. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. Endocrinology. 1995 Oct; 136(10):4415-23.
    View PubMed
  159. Kellermann SA, McCormick DJ, Freeman SL, Morris JC, Conti-Fine BM. TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls. J Autoimmun. 1995 Oct; 8(5):685-98.
    View PubMed
  160. Sheehan MT, Morbeck DE, Bergert ER, McCormick DJ, Milius RP, Morris JC. Receptor-specific activity of heteromeric thyrotropin (TSH) analogs: development of synthetic TSH antagonists. Pept Res. 1995 Sep-Oct; 8(5):264-71.
    View PubMed
  161. Seetharamaiah GS, Wagle NM, Morris JC, Prabhakar BS. Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding. Endocrinology. 1995 Jul; 136(7):2817-24.
    View PubMed
  162. Nagy EV, Morris JC, Burch HB, Bhatia S, Salata K, Burman KD. Thyrotropin receptor T cell epitopes in autoimmune thyroid disease. Clinical Immunology & Immunopathology. 1995 May; 75(2):117-24.
    View PubMed
  163. Levine JA, Morris JC. The use of a football helmet to secure a nasogastric tube. Nutrition. 1995 May-Jun; 11(3):285.
    View PubMed
  164. Bryant WP, Bergert ER, Morris JC, Morris JC. Identification of thyroid blocking antibodies and receptor epitopes in autoimmune hypothyroidism by affinity purification using synthetic TSH receptor peptides. Autoimmunity. 1995; 22 (2):69-79
    View PubMed
  165. Wagle NM, Dallas JS, Morris JC, Prabhakar BS. Thyrotropin receptor specific antibodies in BALB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the IgG1 subclass. 6. 1995 Endocrinology 13; 136: 3461-9.
  166. Bryant WP, Bergert ER, Morris JC. Delineation of amino acid residues within hTSHr 256-275 that participate in hormone binding. J Biol Chem. 1994 Dec 9; 269 (49):30935-8
    View PubMed
  167. Oda RP, Madden BJ, Morris JC, Spelsberg TC, Landers JP. Multiple-buffer-additive strategies for enhanced capillary electrophoretic separation of peptides. J Chromatogr A. 1994 Sep 30; 680(1):341-51.
    View PubMed
  168. Dallas JS, Desai RK, Cunningham SJ, Morris JC, Seetharamaiah GS, Wagle N, Goldblum RM, Prabhakar BS. Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function. Endocrinology. 1994 Mar; 134(3):1437-45.
    View PubMed
  169. Morris JC, Gibson JL, Morris JC, Haas EJ, Bergert ER, Dallas JS, Prabhakar BS. Identification of epitopes and affinity purification of thyroid stimulating auto-antibodies using synthetic human TSH receptor peptides. Autoimmunity. 1994; 17 (4):287-99
    View PubMed
  170. Morris JC, Bergert ER, McCormick DJ. Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem. 1993 May 25; 268 (15):10900-5
    View PubMed
  171. Leinung MC, Bergert ER, McCormick DJ, Morris JC, Morris JC. Synthetic analogs of the carboxyl-terminus of beta-thyrotropin: the importance of basic amino acids in receptor binding activity. Biochemistry. 1992 Oct 20; 31 (41):10094-8
    View PubMed
  172. Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris JC 3rd, Burman KD. Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun. 1992 Oct 15; 188(1):28-33.
    View PubMed
  173. Freeman SL, McCormick DJ, Ryan RJ, Morris JC, Morris JC. Inhibition of TSH bio-activity by synthetic beta TSH peptides. Endocr Res. 1992; 18 (1):1-17
    View PubMed
  174. Leinung MC, Reed DK, McCormick DJ, Ryan RJ, Morris JC, Morris JC. Further characterization of the receptor-binding region of the thyroid-stimulating hormone alpha subunit: a comprehensive synthetic peptide study of the alpha-subunit 26-46 sequence. Proc Natl Acad Sci U S A. 1991 Nov 1; 88 (21):9707-11
    View PubMed
  175. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, O'Connor J, Birken S. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology. 1991 Sep; 129(3):1559-67.
    View PubMed
  176. Charlesworth MC, Bergert ER, Morris JC, McCormick DJ, Ryan RJ. The antigenic structure of the human glycoprotein hormone alpha-subunit: III. Solution- and solid-phase mapping using synthetic peptides. Endocrinology. 1991 Jun; 128(6):2907-15.
    View PubMed
  177. Morris JC, McCormick DJ, Ryan RJ. Inhibition of thyrotropin binding to receptor by synthetic human thyrotropin beta peptides. J Biol Chem. 1990 Feb 5; 265 (4):1881-4
    View PubMed
  178. Morris JC 3rd, Jiang NS, Hay ID, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyroid-stimulating immunoglobulin activity. J Clin Endocrinol Metab. 1988 Oct; 67(4):707-12.
    View PubMed
  179. Morris JC 3rd, Ranganathan G, Hay ID, Nelson RE, Jiang NS. The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology. 1988 Sep; 123(3):1385-94.
    View PubMed
  180. Morris JC 3rd, Jiang NS, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyrotropin interaction with its receptor. Endocrinology. 1988 Jul; 123(1):456-62.
    View PubMed
  181. Morris JC 3rd, Hay ID, Nelson RE, Jiang NS. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc. 1988 Jul; 63 (7):707-17
    View PubMed